SpineGuard 01.09.17
SpineGuard, a company that develops and markets disposable medical devices designed to make spine surgery safer, reported that its consolidated full-year 2016 revenue grew by 18 percent to 7.5 million euros.
“We closed 2016 with a record quarter thanks to solid performances both in the U.S. and in the rest of the world, passing the 2 million euros quarterly mark," CEO and Co-Founder Pierre Jérôme said. "As expected, the recently launched PediGuard Threaded is starting to make an impact in the field, expanding the clinical breadth of our DSG (Dynamic Surgical Guidance) platform technology and bringing new surgeons on board.”
Global revenue in the fourth quarter of 2016 increased 24 percent to 2.15 million euros, compared with 1.73 million euros in the fourth quarter of 2015. In the United States, the growth was 22 percent and 20 percent at constant exchange rate (cc). In the Rest of the World, growth was 40 percent in the fourth quarter of 2016 and 21 percent for the full year.
The company reported that 8,603 DSG enabled devices were sold in fiscal 2016 compared with 7,449 in fiscal 2015. Specifically, 4,948 units were sold in the United States, representing 58 percent of total units sold. Revenue from the United States increased by 17 percent (16 percent cc) to 5.98 million euros compared with 5.12 million euros in fiscal 2015.
Co-founded in 2009 in France and the United States by Jérôme and Stéphane Bette, SpineGuard’s mission is to make spine surgery safer by bringing real-time digital technology into the operating room. Its primary objective is to establish its proprietary DSG technology as the global standard of surgical care, starting with safer screw placement in spine surgery and then in other surgeries.
PediGuard, the first device designed using DSG, was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, a biomedical engineer. It is the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. More than 50,000 surgical procedures have been performed worldwide with DSG enabled devices. Numerous studies published in peer-reviewed medical and scientific journals have demonstrated the multiple benefits that PediGuard delivers to patients, surgical staff and hospitals. SpineGuard is expanding the scope of its DSG platform through strategic partnerships with innovative medical device companies and the development of smart instruments and implants. SpineGuard has offices in San Francisco, Calif., and Paris, France.
“We closed 2016 with a record quarter thanks to solid performances both in the U.S. and in the rest of the world, passing the 2 million euros quarterly mark," CEO and Co-Founder Pierre Jérôme said. "As expected, the recently launched PediGuard Threaded is starting to make an impact in the field, expanding the clinical breadth of our DSG (Dynamic Surgical Guidance) platform technology and bringing new surgeons on board.”
Global revenue in the fourth quarter of 2016 increased 24 percent to 2.15 million euros, compared with 1.73 million euros in the fourth quarter of 2015. In the United States, the growth was 22 percent and 20 percent at constant exchange rate (cc). In the Rest of the World, growth was 40 percent in the fourth quarter of 2016 and 21 percent for the full year.
The company reported that 8,603 DSG enabled devices were sold in fiscal 2016 compared with 7,449 in fiscal 2015. Specifically, 4,948 units were sold in the United States, representing 58 percent of total units sold. Revenue from the United States increased by 17 percent (16 percent cc) to 5.98 million euros compared with 5.12 million euros in fiscal 2015.
Co-founded in 2009 in France and the United States by Jérôme and Stéphane Bette, SpineGuard’s mission is to make spine surgery safer by bringing real-time digital technology into the operating room. Its primary objective is to establish its proprietary DSG technology as the global standard of surgical care, starting with safer screw placement in spine surgery and then in other surgeries.
PediGuard, the first device designed using DSG, was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, a biomedical engineer. It is the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. More than 50,000 surgical procedures have been performed worldwide with DSG enabled devices. Numerous studies published in peer-reviewed medical and scientific journals have demonstrated the multiple benefits that PediGuard delivers to patients, surgical staff and hospitals. SpineGuard is expanding the scope of its DSG platform through strategic partnerships with innovative medical device companies and the development of smart instruments and implants. SpineGuard has offices in San Francisco, Calif., and Paris, France.